G3, Quintiles Enter Target Discovery Alliance

Global Genomics Group (G3) and Quintiles have entered a collaboration to investigate novel biomarkers and biological pathways for use in the development of diagnostic tools and treatments for cardiovascular diseases. Expression Analysis (EA), a Quintiles company, will conduct RNA sequencing, microRNA sequencing and methylation analysis in the GLOBAL (Genetic LOci and Burden of Atherosclerotic Lesions) clinical study.

Read the full article here: http://www.contractpharma.com/contents/view_breaking-news/2014-02-19/g3-quintiles-enter-target-discovery-alliance/#sthash.dMja6rYj.dpuf

G3, Quintiles Enter Target Discovery Alliance
News